Glycosylation of xanthohumol by fungi

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 63, Issue 7-8, 2008, Pages 557-560

  Huszcza, Ewa ^a   Bartmanska, Agnieszka ^a   Tronina, Tomasz ^a  

^a WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

Author keywords

Beauveria bassiana; Biotransformation; Xanthohumol

Indexed keywords

BEAUVERIA; CORDYCEPS BASSIANA; FUNGI;

EID: 51649086376     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2008-7-815     Document Type: Article

References (16)

1. Buckwold V. E., Wilson R. J. H., Nalca A., Beer B. B., Voss T. G., Turpin J. A., Buckheit III R. W. Wei J., Wenzel-Mathers M., Walton E. M., Smith R. J., Pallansch M., Ward P., Wells J., Chuvala L., Sloane S., Paulman R., Russel J., Hartman T., and Ptak R. (2004), Antiviral activity of hop constituents against series of DNA and RNA viruses. Antiviral Res. 61, 57-62.
2. Colgate E. C., Miranda C. L., Stevens J. F., Bray T. M., and Ho E. (2007), Xanthohumol, a prenylflavonoid derived from hops, induces apoptosis and inhibits NP-kappaB activation in prostate epithelial cells. Cancer Lett. 246, 201-209.
3. Grogan G. J. and Holland H. L. (2000), The biocatalytic reactions of Beauveria spp. J. Mol. Cat. 9, 1-32.
4. Guerreiro S., Monteneiro R., Martins M. J., Calhau C., Azevedo I., and Soares R. (2007), Distinct modulation of alkaline phosphatase isoenzymes by 17β-estradiol and xanthohumol in breast cancer MCF-7 cells. Clinical Biochem. 40, 268-273.
5. Herath H. M. W., Ferreira D., and Khan J. A. (2003). Microbial transformation of xanthohumol. Phytochemistry 62, 673-677.
6. Hodek P., Trefil P., and Stiborova M. (2002), Flavonoids - potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 139, 1-29.
7. th International Commodity Science Conference, Poznań, Poland, pp. 817-822.
8. Kim H. J. and Lee I. S. (2006), Microbial metabolism of the prenylated chalcone xanthohumol. J. Nat. Prod. 69, 1522-1524.
9. Miranda C. L., Aponso G. L. M., Stevens J. F., Deinzer M. L., and Buhler D. R. (2000), Prenylated chalcones and flavanones as inducers of quinine reductase in mouse Hepa lclc7 cells. Cancer Lett. 149, 21-29.
10. Nookandeh A., Frank N., Steiner F., Ellinger R., Schneider B., Gerhäuser C., and Becker H. (2004), Xanthohumol metabolites in faeces of rats. Phytochemistry 65, 561-570.
11. Stevens J. F., Ivanic M., Hsu V., and Deinzer M. L. (1997), Prenylflavonoids from Humulus lupulus. Phytochemistry 44, 1575-1585.
12. Tahara S., Tanaka M., and Barz W. (1997), Fungal metabolism of prenylated flavonoids. Phytochemistry 44, 1031-1036.
13. Tobe H., Kitamura K., and Komiyama O. (1997), Pharmaceutical composition for treating osteoporosis. Patent US 5, 679, 716.
14. Wang Q., Ding Z. H., Liu J. K., and Zheng Y. T. (2004), Xanthohumol, a novel anti-HIV-1 agent purified from hops Humulus lupulus. Antiviral Res. 64, 189-194.
15. Yilmazer M., Stevens J. F., and Buhler D. R. (2001a), In vitro glucuronidation of xanthohumol, a flavonoid in hop and beer, by rat and human liver microsomes. FEBS Lett. 491, 252-256.
16. Yilmazer M., Stevens J. F., Deinzer M. L., and Buhler D. R. (2001b), In vitro biotransformation of xanthohumol, a flavonoid from hops (Humulus lupulus), by rat liver microsomes. Drug Metab. Dispos. 29, 223-231.